Restricted Research - Award List, Note/Discussion Page

Fiscal Year: 2018

1698  University of Houston  (75516)

Principal Investigator: Wei Wang

Total Amount of Contract, Award, or Gift (Annual before 2011): $ 489,310

Exceeds $250,000 (Is it flagged?): Yes

Start and End Dates: 9/1/17 - 6/30/19

Restricted Research: YES

Academic Discipline: PHARMACOLOGICAL & PHARMACEUTIC

Department, Center, School, or Institute: DEAN, PHARMACY

Title of Contract, Award, or Gift: TARGETING MDM2 ONCOGENE TO TREAT BREAST CANCER

Name of Granting or Contracting Agency/Entity: American Cancer Society

Program Title: RESEARCH SCHOLAR GRANTS

Note:

1.1.1 - The applicants are now proposing to test SP141 for its therapeutic efficacy and safety in more clinically relevant breast cancer models and characterize its pharmacological properties. They are also proposing to further demonstrate how the new compound kills cancer cells.

Discussion: No discussion notes

 

Close Window